JAMA garlic/cholesterol study
This article was originally published in The Tan Sheet
Executive Summary
Finds garlic had no effect on cholesterol levels, cholesterol absorption or cholesterol synthesis, Heiner Berthold, MD/PhD, University of Bonn, et al., report in the June 17 Journal of the American Medical Association. The three endpoints were "virtually unchanged" after the 12-week study, leading the researchers to conclude garlic cannot be recommended for treatment of hypercholesterolemia on the basis of the trial. During the 12-week, randomized, double-blind, placebo-controlled, cross-over study, 25 moderate hypercholesterolemic patients (average total cholesterol of 291 mg/dL) received either 5 mg enteric-coated steam-distilled garlic oil (Tegra, Hermes Arzneimittel, Munich) or a garlic-flavored placebo. CRN and Lichtwer Pharma (marketer of Kwai garlic) issued statements challenging the study's importance in light of other evidence; both note the study used garlic oil, not powdered garlic, which they say is more effective...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning